Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Net Income 2010-2025 | AMGN

Amgen annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending March 31, 2025 was $1.730B, a 1630.97% decline year-over-year.
  • Amgen net income for the twelve months ending March 31, 2025 was $5.933B, a 57.67% increase year-over-year.
  • Amgen annual net income for 2024 was $4.09B, a 39.11% decline from 2023.
  • Amgen annual net income for 2023 was $6.717B, a 2.52% increase from 2022.
  • Amgen annual net income for 2022 was $6.552B, a 11.18% increase from 2021.
  
Amgen Annual Net Income
(Millions of US $)
2024 $4,090
2023 $6,717
2022 $6,552
2021 $5,893
2020 $7,264
2019 $7,842
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
Amgen Quarterly Net Income
(Millions of US $)
2025-03-31 $1,730
2024-12-31 $627
2024-09-30 $2,830
2024-06-30 $746
2024-03-31 $-113
2023-12-31 $767
2023-09-30 $1,730
2023-06-30 $1,379
2023-03-31 $2,841
2022-12-31 $1,616
2022-09-30 $2,143
2022-06-30 $1,317
2022-03-31 $1,476
2021-12-31 $1,899
2021-09-30 $1,884
2021-06-30 $464
2021-03-31 $1,646
2020-12-31 $1,615
2020-09-30 $2,021
2020-06-30 $1,803
2020-03-31 $1,825
2019-12-31 $1,703
2019-09-30 $1,968
2019-06-30 $2,179
2019-03-31 $1,992
2018-12-31 $1,928
2018-09-30 $1,859
2018-06-30 $2,296
2018-03-31 $2,311
2017-12-31 $-4,264
2017-09-30 $2,021
2017-06-30 $2,151
2017-03-31 $2,071
2016-12-31 $1,935
2016-09-30 $2,017
2016-06-30 $1,870
2016-03-31 $1,900
2015-12-31 $1,800
2015-09-30 $1,863
2015-06-30 $1,653
2015-03-31 $1,623
2014-12-31 $1,294
2014-09-30 $1,244
2014-06-30 $1,547
2014-03-31 $1,073
2013-12-31 $1,021
2013-09-30 $1,368
2013-06-30 $1,258
2013-03-31 $1,434
2012-12-31 $788
2012-09-30 $1,107
2012-06-30 $1,266
2012-03-31 $1,184
2011-12-31 $934
2011-09-30 $454
2011-06-30 $1,170
2011-03-31 $1,125
2010-12-31 $1,022
2010-09-30 $1,236
2010-06-30 $1,202
2010-03-31 $1,167
2009-12-31 $931
2009-09-30 $1,386
2009-06-30 $1,269
2009-03-31 $1,019
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $161.511B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $222.705B 16.62
Gilead Sciences (GILD) United States $142.480B 14.80
Vertex Pharmaceuticals (VRTX) United States $123.142B 0.00
Bristol Myers Squibb (BMY) United States $98.742B 6.61
GSK (GSK) United Kingdom $81.034B 9.70
CSL (CSLLY) Australia $78.181B 0.00
Regeneron Pharmaceuticals (REGN) United States $60.435B 14.67
Alnylam Pharmaceuticals (ALNY) United States $42.069B 0.00
Argenex SE (ARGX) Netherlands $34.395B 93.89
BioNTech SE (BNTX) Germany $27.386B 0.00
Royalty Pharma (RPRX) United States $20.308B 8.58
Biogen (BIIB) United States $19.830B 8.55
Insmed (INSM) United States $18.338B 0.00
Illumina (ILMN) United States $15.838B 30.05
Genmab (GNMSF) Denmark $14.044B 14.36
Genmab (GMAB) Denmark $14.024B 15.73
Incyte (INCY) United States $13.616B 103.44
Moderna (MRNA) United States $13.258B 0.00
Exelixis (EXEL) United States $12.318B 20.91
BioMarin Pharmaceutical (BMRN) United States $11.280B 18.32
QIAGEN (QGEN) Netherlands $10.792B 21.00
Ascendis Pharma (ASND) Denmark $10.789B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.058B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.926B 0.00
Bio-Techne Corp (TECH) United States $8.530B 31.82
Blueprint Medicines (BPMC) United States $8.352B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.191B 0.00
Roivant Sciences (ROIV) United Kingdom $7.865B 0.00
Repligen (RGEN) United States $7.529B 84.28
Anbio Biotechnology (NNNN) Germany $7.300B 0.00
Legend Biotech (LEGN) United States $7.297B 0.00
Revolution Medicines (RVMD) United States $7.171B 0.00
Halozyme Therapeutics (HALO) United States $7.101B 13.59
Jazz Pharmaceuticals (JAZZ) Ireland $6.806B 6.68
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Guardant Health (GH) United States $6.354B 0.00
TG Therapeutics (TGTX) United States $5.980B 156.96
Nuvalent (NUVL) United States $5.893B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.665B 0.00
Axsome Therapeutics (AXSM) United States $5.452B 0.00
Telix Pharmaceuticals (TLX) Australia $5.448B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.095B 0.00
Alkermes (ALKS) Ireland $5.023B 13.48
Vaxcyte (PCVX) United States $4.675B 0.00
ADMA Biologics Inc (ADMA) United States $4.409B 32.98
Cytokinetics (CYTK) United States $4.370B 0.00
Krystal Biotech (KRYS) United States $4.327B 33.35
Zealand Pharma (ZLDPF) Denmark $4.230B 0.00
Akero Therapeutics (AKRO) United States $4.145B 0.00
PTC Therapeutics (PTCT) United States $3.925B 6.83
Metsera (MTSR) United States $3.825B 0.00
Merus (MRUS) Netherlands $3.814B 0.00
Arcellx (ACLX) United States $3.795B 0.00
Avidity Biosciences (RNA) United States $3.793B 0.00
Zai Lab (ZLAB) China $3.786B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.692B 32.44
Scholar Rock Holding (SRRK) United States $3.619B 0.00
Ascentage Pharma Group - (AAPG) China $3.549B 0.00
Viking Therapeutics (VKTX) United States $3.514B 0.00
Protagonist Therapeutics (PTGX) United States $3.274B 70.43
MoonLake Immunotherapeutics (MLTX) Switzerland $3.129B 0.00
Immunovant (IMVT) United States $2.994B 0.00
Kymera Therapeutics (KYMR) United States $2.944B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.934B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.784B 0.00
Alvotech (ALVO) Luxembourg $2.632B 15.05
Mirum Pharmaceuticals (MIRM) United States $2.626B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.605B 0.00
ImmunityBio (IBRX) United States $2.533B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.531B 0.00
Apellis Pharmaceuticals (APLS) United States $2.455B 0.00
Ligand Pharmaceuticals (LGND) United States $2.411B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.323B 0.00
Twist Bioscience (TWST) United States $2.305B 0.00
Agios Pharmaceuticals (AGIO) United States $2.289B 0.00
Bavarian Nordic (BVNRY) Denmark $2.252B 11.90
Denali Therapeutics (DNLI) United States $2.230B 0.00
Beam Therapeutics (BEAM) United States $2.215B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.113B 0.00
Vericel (VCEL) United States $2.076B 1374.33
CG Oncology (CGON) United States $2.066B 0.00
NovoCure (NVCR) Jersey $2.058B 0.00
Disc Medicine (IRON) United States $2.009B 0.00
IDEAYA Biosciences (IDYA) United States $1.997B 0.00
Belite Bio (BLTE) United States $1.975B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.971B 13.10
Amicus Therapeutics (FOLD) United States $1.940B 210.00
Sarepta Therapeutics (SRPT) United States $1.874B 0.00
Certara (CERT) United States $1.866B 34.85
Adaptive Biotechnologies (ADPT) United States $1.835B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.820B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.781B 0.00
Apogee Therapeutics (APGE) United States $1.776B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.729B 0.00
89BIO (ETNB) United States $1.574B 0.00
GRAIL (GRAL) United States $1.561B 0.00
Vera Therapeutics (VERA) United States $1.553B 0.00
Biohaven (BHVN) United States $1.535B 0.00
Janux Therapeutics (JANX) United States $1.515B 0.00
Celldex Therapeutics (CLDX) United States $1.506B 0.00
Travere Therapeutics (TVTX) United States $1.470B 0.00
Edgewise Therapeutics (EWTX) United States $1.459B 0.00
ANI Pharmaceuticals (ANIP) United States $1.432B 14.75
Mesoblast (MESO) Australia $1.408B 0.00
Viridian Therapeutics (VRDN) United States $1.398B 0.00
Dynavax Technologies (DVAX) United States $1.309B 77.86
AbCellera Biologics (ABCL) Canada $1.268B 0.00
Intellia Therapeutics (NTLA) United States $1.260B 0.00
WAVE Life Sciences (WVE) Singapore $1.237B 0.00
Cogent Biosciences (COGT) United States $1.235B 0.00
CureVac (CVAC) Germany $1.223B 5.92
Liquidia Technologies (LQDA) United States $1.210B 0.00
MannKind (MNKD) United States $1.155B 23.75
Novavax (NVAX) United States $1.150B 2.68
Pacira BioSciences (PCRX) United States $1.097B 10.44
Structure Therapeutics (GPCR) United States $1.084B 0.00
Pharvaris (PHVS) Netherlands $1.037B 0.00
Cidara Therapeutics (CDTX) United States $1.026B 0.00
Praxis Precision Medicines (PRAX) United States $1.025B 0.00
Arcus Biosciences (RCUS) United States $1.010B 0.00
MiMedx (MDXG) United States $1.001B 24.21
Oric Pharmaceuticals (ORIC) United States $0.976B 0.00
Nurix Therapeutics (NRIX) United States $0.969B 0.00
LENZ Therapeutics (LENZ) United States $0.964B 0.00
NeoGenomics (NEO) United States $0.964B 0.00
Spyre Therapeutics (SYRE) United States $0.962B 0.00
Anavex Life Sciences (AVXL) United States $0.954B 0.00
Mineralys Therapeutics (MLYS) United States $0.954B 0.00
Zymeworks (ZYME) United States $0.952B 0.00
BGM Group (BGM) China $0.939B 0.00
Niagen Bioscience (NAGE) United States $0.929B 131.00
Sionna Therapeutics (SION) United States $0.924B 0.00
Sana Biotechnology (SANA) United States $0.915B 0.00
Geron (GERN) United States $0.879B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.845B 0.00
GH Research (GHRS) Ireland $0.835B 0.00
Replimune (REPL) United States $0.830B 0.00
Vir Biotechnology (VIR) United States $0.820B 0.00
UniQure (QURE) Netherlands $0.815B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Oculis Holding AG (OCS) Switzerland $0.803B 0.00
CorMedix Inc (CRMD) United States $0.794B 53.23
Nuvation Bio (NUVB) United States $0.786B 0.00
Immunome (IMNM) United States $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
AnaptysBio (ANAB) United States $0.767B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.761B 0.00
ArriVent BioPharma (AVBP) United States $0.754B 0.00
Trevi Therapeutics (TRVI) United States $0.752B 0.00
Gyre Therapeutics (GYRE) United States $0.732B 195.25
Immatics (IMTX) Germany $0.729B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.729B 0.00
MeiraGTx Holdings (MGTX) United States $0.693B 0.00
Jyong Biotech (MENS) Taiwan $0.693B 0.00
Maze Therapeutics (MAZE) United States $0.685B 0.00
Pharming Group (PHAR) Netherlands $0.680B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.677B 0.00
Urogen Pharma (URGN) United States $0.675B 0.00
Dianthus Therapeutics (DNTH) United States $0.663B 0.00
Tango Therapeutics (TNGX) United States $0.662B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.660B 0.00
Stoke Therapeutics (STOK) United States $0.657B 15.24
Sinovac Biotech (SVA) China $0.645B 0.00
Iovance Biotherapeutics (IOVA) United States $0.644B 0.00
Upstream Bio (UPB) United States $0.637B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.632B 0.00
Prime Medicine (PRME) United States $0.631B 0.00
Arbutus Biopharma (ABUS) United States $0.628B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.612B 0.00
Keros Therapeutics (KROS) United States $0.588B 0.00
Sage Therapeutics (SAGE) United States $0.577B 0.00
Arvinas (ARVN) United States $0.576B 0.00
Castle Biosciences (CSTL) United States $0.573B 38.90
Precigen (PGEN) United States $0.564B 0.00
Rapport Therapeutics (RAPP) United States $0.561B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.560B 0.00
Kura Oncology (KURA) United States $0.551B 0.00
Tyra Biosciences (TYRA) United States $0.544B 0.00
Bicara Therapeutics (BCAX) United States $0.541B 0.00
Abivax SA (ABVX) France $0.527B 0.00
Opthea (OPT) Australia $0.525B 0.00
Septerna (SEPN) United States $0.520B 0.00
Celcuity (CELC) United States $0.516B 0.00
Myriad Genetics (MYGN) United States $0.507B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
Zenas BioPharma (ZBIO) United States $0.505B 0.00
Fortrea Holdings (FTRE) United States $0.477B 13.18
ATyr Pharma (ATYR) United States $0.474B 0.00
Cullinan Therapeutics (CGEM) United States $0.463B 0.00
Kamada (KMDA) Israel $0.461B 27.66
REGENXBIO (RGNX) United States $0.454B 0.00
Cytek Biosciences (CTKB) United States $0.451B 0.00
Rezolute (RZLT) United States $0.449B 0.00
Fulcrum Therapeutics (FULC) United States $0.432B 0.00
Erasca (ERAS) United States $0.431B 0.00
PureTech Health (PRTC) United States $0.430B 0.00
Terns Pharmaceuticals (TERN) United States $0.425B 0.00
Solid Biosciences (SLDB) United States $0.420B 0.00
Eton Pharmaceuticals (ETON) United States $0.417B 0.00
MBX Biosciences (MBX) United States $0.414B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.408B 0.00
Tectonic Therapeutic (TECX) United States $0.406B 0.00
Emergent Biosolutions (EBS) United States $0.398B 0.00
Compass Therapeutics (CMPX) United States $0.394B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.393B 0.00
ITeos Therapeutics (ITOS) United States $0.391B 0.00
Humacyte (HUMA) United States $0.389B 0.00
Vigil Neuroscience (VIGL) United States $0.383B 0.00
Astria Therapeutics (ATXS) United States $0.376B 0.00
Benitec Biopharma (BNTC) United States $0.362B 0.00
Amarin (AMRN) Ireland $0.359B 0.00
Prothena (PRTA) Ireland $0.354B 0.00
Cartesian Therapeutics (RNAC) United States $0.351B 0.00
Absci (ABSI) United States $0.348B 0.00
Aura Biosciences (AURA) United States $0.340B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.337B 0.00
Ocugen (OCGN) United States $0.336B 0.00
XOMA Royalty (XOMA) United States $0.334B 0.00
Olema Pharmaceuticals (OLMA) United States $0.332B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.327B 0.00
Northwest Biotherapeutics (NWBO) United States $0.325B 0.00
Lifecore Biomedical (LFCR) United States $0.325B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.324B 65.75
Atea Pharmaceuticals (AVIR) United States $0.323B 0.00
Inventiva S.A (IVA) France $0.323B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.316B 0.00
Neurogene (NGNE) United States $0.313B 0.00
Gossamer Bio (GOSS) United States $0.309B 0.00
Candel Therapeutics (CADL) United States $0.308B 0.00
Annexon (ANNX) United States $0.307B 0.00
Sagimet Biosciences (SGMT) United States $0.304B 0.00
Inhibrx Biosciences (INBX) United States $0.304B 0.18
Foghorn Therapeutics (FHTX) United States $0.301B 0.00
Abeona Therapeutics (ABEO) United States $0.299B 0.00
Palvella Therapeutics (PVLA) United States $0.298B 0.00
DBV Technologies S.A (DBVT) France $0.297B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.294B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.290B 0.00
Vor Biopharma (VOR) $0.289B 0.00
Alpha Teknova (TKNO) United States $0.277B 0.00
Cardiff Oncology (CRDF) United States $0.277B 0.00
Allogene Therapeutics (ALLO) United States $0.276B 0.00
Aardvark Therapeutics (AARD) United States $0.273B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.269B 0.00
Crescent Biopharma (CBIO) United States $0.264B 0.00
Verastem (VSTM) United States $0.260B 0.00
Codexis (CDXS) United States $0.258B 0.00
Entrada Therapeutics (TRDA) United States $0.257B 8.35
Editas Medicine (EDIT) United States $0.256B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
MaxCyte (MXCT) United States $0.243B 0.00
Prima BioMed (IMMP) Australia $0.240B 0.00
Kodiak Sciences (KOD) United States $0.237B 0.00
ScPharmaceuticals (SCPH) United States $0.236B 0.00
Monopar Therapeutics (MNPR) United States $0.234B 0.00
Citius Oncology (CTOR) United States $0.233B 0.00
Design Therapeutics (DSGN) United States $0.229B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Adocia (ADOCY) France $0.216B 0.00
Tvardi Therapeutics (TVRD) United States $0.212B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
AC Immune (ACIU) Switzerland $0.212B 0.00
CytomX Therapeutics (CTMX) United States $0.210B 5.42
BioStem Technologies (BSEM) $0.208B 8.47
Eledon Pharmaceuticals (ELDN) United States $0.207B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.205B 0.00
Ventyx Biosciences (VTYX) United States $0.202B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.202B 0.00
Voyager Therapeutics (VYGR) United States $0.196B 0.00
Alumis (ALMS) United States $0.194B 0.00
SELLAS Life Sciences (SLS) United States $0.189B 0.00
EnGene Holdings (ENGN) Canada $0.188B 0.00
GENFIT S.A (GNFT) France $0.188B 0.00
Bright Minds Biosciences (DRUG) United States $0.183B 0.00
Alpha Cognition (ACOG) Canada $0.176B 0.00
Instil Bio (TIL) United States $0.176B 0.00
Puma Biotechnology (PBYI) United States $0.175B 4.57
Alector (ALEC) United States $0.172B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.172B 0.00
Neumora Therapeutics (NMRA) United States $0.171B 0.00
Nuvectis Pharma (NVCT) United States $0.171B 0.00
Anika Therapeutics (ANIK) United States $0.169B 0.00
BioAge Labs (BIOA) United States $0.168B 0.00
I-Mab (IMAB) United States $0.167B 0.00
Innate Pharma S.A (IPHA) France $0.167B 0.00
Agenus (AGEN) United States $0.162B 0.00
Caribou Biosciences (CRBU) United States $0.162B 0.00
Spero Therapeutics (SPRO) United States $0.159B 0.00
DiaMedica Therapeutics (DMAC) United States $0.157B 0.00
Immuneering (IMRX) United States $0.156B 0.00
Black Diamond Therapeutics (BDTX) United States $0.156B 45.67
Kyverna Therapeutics (KYTX) United States $0.154B 0.00
Compugen (CGEN) Israel $0.151B 0.00
Greenwich LifeSciences (GLSI) United States $0.150B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.149B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.149B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.143B 0.00
Rapt Therapeutics (RAPT) United States $0.143B 0.00
C4 Therapeutics (CCCC) United States $0.141B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.137B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Fate Therapeutics (FATE) United States $0.133B 0.00
Elicio Therapeutics (ELTX) United States $0.132B 0.00
Genelux (GNLX) United States $0.130B 0.00
Seer (SEER) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Skye Bioscience (SKYE) United States $0.122B 0.00
Actuate Therapeutics (ACTU) United States $0.121B 0.00
BioHarvest Sciences (BHST) Canada $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.115B 0.00
Tenaya Therapeutics (TNYA) United States $0.112B 0.00
TuHURA Biosciences (HURA) United States $0.110B 0.00
Seres Therapeutics (MCRB) United States $0.108B 0.00
Coya Therapeutics (COYA) United States $0.106B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Oncolytics Biotech (ONCY) Canada $0.105B 0.00
Contineum Therapeutics (CTNM) United States $0.104B 0.00
TScan Therapeutics (TCRX) United States $0.104B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elutia (ELUT) United States $0.101B 0.00
Coherus Oncology (CHRS) United States $0.101B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.099B 0.00
OKYO Pharma (OKYO) $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.095B 0.00
Zura Bio (ZURA) United States $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.093B 0.00
IO Biotech (IOBT) Denmark $0.092B 0.00
Cellectis S.A (CLLS) France $0.092B 0.00
Adagene (ADAG) China $0.091B 0.00
Climb Bio (CLYM) United States $0.091B 0.00
BeyondSpring (BYSI) United States $0.091B 0.00
XBiotech (XBIT) United States $0.090B 0.00
Invivyd (IVVD) United States $0.089B 0.00
Cabaletta Bio (CABA) United States $0.088B 0.00
Pliant Therapeutics (PLRX) United States $0.086B 0.00
EXoZymes (EXOZ) United States $0.084B 0.00
Entera Bio (ENTX) Israel $0.084B 0.00
TELA Bio (TELA) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Quince Therapeutics (QNCX) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.079B 0.00
Immix Biopharma (IMMX) United States $0.076B 0.00
Forte Biosciences (FBRX) United States $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.073B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.073B 0.00
Biomea Fusion (BMEA) United States $0.073B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.068B 0.00
Oncobiologics (OTLK) United States $0.068B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
Connect Biopharma Holdings (CNTB) United States $0.064B 0.00
CervoMed (CRVO) United States $0.063B 0.00
MediciNova (MNOV) United States $0.062B 0.00
Adicet Bio (ACET) United States $0.061B 0.00
Senti Biosciences (SNTI) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
Cue Biopharma (CUE) United States $0.060B 0.00
PDS Biotechnology (PDSB) United States $0.059B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.059B 0.00
ABVC BioPharma (ABVC) United States $0.057B 0.00
Adverum Biotechnologies (ADVM) United States $0.057B 0.00
Atara Biotherapeutics (ATRA) United States $0.057B 0.00
VTv Therapeutics (VTVT) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.056B 0.00
Annovis Bio (ANVS) United States $0.056B 0.00
Quantum Biopharma (QNTM) Canada $0.055B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
Jasper Therapeutics (JSPR) United States $0.053B 0.00
INmune Bio (INMB) United States $0.053B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
Celularity (CELU) United States $0.052B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Renovaro (RENB) United States $0.051B 0.00
Inovio Pharmaceuticals (INO) United States $0.051B 0.00
RenovoRx (RNXT) United States $0.049B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
Mersana Therapeutics (MRSN) United States $0.047B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
Exicure (XCUR) United States $0.046B 0.00
Scilex Holding (SCLX) United States $0.045B 0.00
Medicus Pharma (MDCX) United States $0.045B 0.00
KALA BIO (KALA) United States $0.045B 0.00
Artiva Biotherapeutics (ARTV) United States $0.044B 0.00
Cognition Therapeutics (CGTX) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
Rani Therapeutics Holdings (RANI) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Shattuck Labs (STTK) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Hyperion DeFi (HYPD) United States $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Kezar Life Sciences (KZR) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.034B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
Femasys (FEMY) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Ovid Therapeutics (OVID) United States $0.030B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
FibroBiologics (FBLG) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Generation Bio (GBIO) United States $0.025B 0.00
Passage Bio (PASG) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
CalciMedica (CALC) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Curis (CRIS) United States $0.020B 0.00
Hoth Therapeutics (HOTH) United States $0.020B 0.00
Cingulate (CING) United States $0.019B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.017B 0.00
Advanced Biomed (ADVB) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.017B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.017B 0.00
Rallybio (RLYB) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Artelo Biosciences (ARTL) United States $0.016B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
Equillium (EQ) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Synaptogenix (TAOX) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Novogen (KZIA) Australia $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
LakeShore Biopharma (LSB) China $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
GENPREX (GNPX) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
X4 Pharmaceuticals (XFOR) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00